Study suggests that attention networks support changes in cortical organization and cognition during childhood

by Ingrid Fadelli , Medical XpressVentral attention network areas demonstrate high population-level degree centrality but pronounced functional changes across development. Credit:Nature Neurosci

Updated on: September 23,2024 0

Study suggests that attention networks support changes in cortical organization and cognition during childhood

by Ingrid Fadelli , Medical XpressVentral attention network areas demonstrate high population-level degree centrality but pronounced functional changes across development. Credit:Nature Neurosci

Updated on:September 23,2024 0

Antihypertensive drugs are effective in hereditary cerebral small vessel disease

by Niigata UniversityTherapeutic effect of candesartan on cerebral arteriopathy via inhibition of matrisome protein accumulation. Credit: Niigata UniversityOur brains have small arteries that perform

Updated on: June 24,2024 6

Antihypertensive drugs are effective in hereditary cerebral small vessel disease

by Niigata UniversityTherapeutic effect of candesartan on cerebral arteriopathy via inhibition of matrisome protein accumulation. Credit: Niigata UniversityOur brains have small arteries that perform

Updated on:June 24,2024 6

Roots of Alzheimer's disease can extend as far back as the womb

by University of British ColumbiaDr. Weihong Song is a Professor of Psychiatry at University of British Columbia. Credit: University of British ColumbiaBiochemical reactions that cause Alzheimer&

Updated on: April 07,2024 15

Roots of Alzheimer's disease can extend as far back as the womb

by University of British ColumbiaDr. Weihong Song is a Professor of Psychiatry at University of British Columbia. Credit: University of British ColumbiaBiochemical reactions that cause Alzheimer&

Updated on:April 07,2024 15

FDA approves Miplyffa for treatment of Niemann-Pick disease, type C

by Lori SolomonThe U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, i

Updated on: November 11,2024 0

FDA approves Miplyffa for treatment of Niemann-Pick disease, type C

by Lori SolomonThe U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa (arimoclomol), an oral medication for the treatment of Niemann-Pick disease, type C (NPC).Miplyffa, i

Updated on:November 11,2024 0

Genetic 'whiteout' offers hope to children living with dementia

by Murdoch UniversityChildren living with dementia have the same symptoms as adults with dementia, in that they are losing memories and face a gradual decline in health, with most not reaching ad

Updated on: June 14,2024 7

Genetic 'whiteout' offers hope to children living with dementia

by Murdoch UniversityChildren living with dementia have the same symptoms as adults with dementia, in that they are losing memories and face a gradual decline in health, with most not reaching ad

Updated on:June 14,2024 7

Neurons in mouse piriform cortex aid in recurrent circuit development, study finds

by Ingrid Fadelli , Medical XpressEmbryonically active neurons labeled in brain-wide regions, highlighting particularly dense and broad activation in piriform cortex (also known as primary olfactory c

Updated on: October 16,2024 0

Neurons in mouse piriform cortex aid in recurrent circuit development, study finds

by Ingrid Fadelli , Medical XpressEmbryonically active neurons labeled in brain-wide regions, highlighting particularly dense and broad activation in piriform cortex (also known as primary olfactory c

Updated on:October 16,2024 0

Movement disorder ALS and cognitive disorder FTLD show strong molecular overlaps, new study shows

byMassachusetts Institute of TechnologyStained motor cortex tissue from a donor with ALS (right) shows reduced amounts of the protein HLA-E (green) in the vasculature. HLA-E is thought to inhibi

Updated on: March 28,2024 0

Movement disorder ALS and cognitive disorder FTLD show strong molecular overlaps, new study shows

byMassachusetts Institute of TechnologyStained motor cortex tissue from a donor with ALS (right) shows reduced amounts of the protein HLA-E (green) in the vasculature. HLA-E is thought to inhibi

Updated on:March 28,2024 0

Systemic sclerosis is on the rise in Quebec, especially in children, study finds

by Claire Loewen,McGill UniversityAge-standardized incidence rates (ASIR) over time (1996–2019) for females, males, and both. The gray shading depicts the 95% confidence intervals for the annual

Updated on: July 17,2024 0

Systemic sclerosis is on the rise in Quebec, especially in children, study finds

by Claire Loewen,McGill UniversityAge-standardized incidence rates (ASIR) over time (1996–2019) for females, males, and both. The gray shading depicts the 95% confidence intervals for the annual

Updated on:July 17,2024 0

Get a free memory screening from the Alzheimer's foundation this November

by Cara MurezEarly detection of memory issues is important.It can help rule in or out a variety of health issues, includingvitamin deficiency, thyroid condition,sleep apnea,urinary t

Updated on: July 01,2024 4

Get a free memory screening from the Alzheimer's foundation this November

by Cara MurezEarly detection of memory issues is important.It can help rule in or out a variety of health issues, includingvitamin deficiency, thyroid condition,sleep apnea,urinary t

Updated on:July 01,2024 4

GluN3A knockout mouse: Alternative model for Alzheimer's neurodegeneration

by Emory UniversityGluN3A (in the diagram, NR3) is an inhibitory subunit within NMDA receptor assemblies, which function as glutamate-gated cation channels. GluN3A is a key regulator of neuronal

Updated on: March 30,2024 20

GluN3A knockout mouse: Alternative model for Alzheimer's neurodegeneration

by Emory UniversityGluN3A (in the diagram, NR3) is an inhibitory subunit within NMDA receptor assemblies, which function as glutamate-gated cation channels. GluN3A is a key regulator of neuronal

Updated on:March 30,2024 20

Critical care admissions for people with dementia are increasing for those in their last year of life, study finds

by King's College LondonCredit: Pixabay/CC0 Public DomainA study led by the Cicely Saunders Institute at King's College London has found that while critical care admissions for people wit

Updated on: March 02,2024 15

Critical care admissions for people with dementia are increasing for those in their last year of life, study finds

by King's College LondonCredit: Pixabay/CC0 Public DomainA study led by the Cicely Saunders Institute at King's College London has found that while critical care admissions for people wit

Updated on:March 02,2024 15

Not just a 'bad guy': Researchers discover neuroprotective function of Tau protein

by Rajalaxmi Natarajan,Baylor College of MedicineOverexpression of hTau in glia disrupts LDs and glial cell morphology in response to neuronal ROS. Credit:Nature Neuroscience(2024).

Updated on: September 06,2024 0

Not just a 'bad guy': Researchers discover neuroprotective function of Tau protein

by Rajalaxmi Natarajan,Baylor College of MedicineOverexpression of hTau in glia disrupts LDs and glial cell morphology in response to neuronal ROS. Credit:Nature Neuroscience(2024).

Updated on:September 06,2024 0